Entasis Therapeutics Holdings Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 13.297 million compared to USD 13.480 million a year ago. Net loss was USD 12.030 million compared to USD 13.396 million a year ago. Basic loss per share from continuing operations was USD 0.29 compared to USD 0.78 a year ago. For the half year, operating loss was USD 25.974 million compared to USD 28.883 million a year ago. Net loss was USD 22.731 million compared to USD 28.662 million a year ago. Basic loss per share from continuing operations was USD 0.58 compared to USD 1.89 a year ago.